Sanofi Consumer Healthcare India Ltd
- Market Cap ₹ 11,400 Cr.
- Current Price ₹ 4,950
- High / Low ₹ 5,499 / 4,212
- Stock P/E 56.6
- Book Value ₹ 119
- Dividend Yield 1.11 %
- ROCE 111 %
- ROE 83.8 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 41.7 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational
Part of BSE Allcap Nifty Microcap 250 Nifty Total Market BSE Healthcare BSE SmallCap
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Dec 2023 8m | Dec 2024 | |
---|---|---|
555 | 724 | |
337 | 454 | |
Operating Profit | 219 | 271 |
OPM % | 39% | 37% |
2 | -15 | |
Interest | 0 | 4 |
Depreciation | 2 | 4 |
Profit before tax | 219 | 247 |
Tax % | 25% | 27% |
165 | 181 | |
EPS in Rs | 78.59 | |
Dividend Payout % | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 30% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 21% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 84% |
Balance Sheet
Figures in Rs. Crores
Dec 2023 | Dec 2024 | |
---|---|---|
Equity Capital | 2 | 23 |
Reserves | 206 | 250 |
0 | 20 | |
138 | 138 | |
Total Liabilities | 345 | 431 |
5 | 29 | |
CWIP | 3 | 1 |
Investments | 0 | 0 |
338 | 402 | |
Total Assets | 345 | 431 |
Cash Flows
Figures in Rs. Crores
Dec 2023 | Dec 2024 | |
---|---|---|
-0 | 439 | |
0 | 2 | |
2 | -116 | |
Net Cash Flow | 2 | 325 |
Ratios
Figures in Rs. Crores
Dec 2023 | Dec 2024 | |
---|---|---|
Debtor Days | 21 | 7 |
Inventory Days | 232 | 80 |
Days Payable | 144 | 138 |
Cash Conversion Cycle | 109 | -51 |
Working Capital Days | 134 | -31 |
ROCE % | 111% |
Documents
Announcements
-
Updates on Open Offer
17h - Open offer to acquire 26% shares of Sanofi Consumer Healthcare by Opal Bidco and partners.
-
Corrigendum To The Annual Report For Financial Year 2024
1d - Corrigendum issued correcting foreign exchange figures in FY24 Annual Report.
- Reg. 34 (1) Annual Report. 1d
-
Letter of Offer
16 Apr - Open offer for 26% stake in Sanofi Consumer Healthcare India by Opal Bidco SAS and CD&R.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - Certificate under Reg 74(5) of the SEBI (Depositories and Participants) regulations, 2018 for quarter ended March 31, 2025.